{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:18:11Z","timestamp":1770333491435,"version":"3.49.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109034","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T14:01:51Z","timestamp":1412172111000},"page":"e109034","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant"],"prefix":"10.1371","volume":"9","author":[{"given":"Kashif","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath","family":"Samaratunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Fogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall I.","family":"Hertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2010.08.004","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report\u20132010","volume":"29","author":"JD Christie","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"A Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bmt.2013.222","article-title":"NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT","volume":"49","author":"KM Williams","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1513\/pats.200807-073GO","article-title":"Chronic lung allograft rejection: mechanisms and therapy","volume":"6","author":"JA Belperio","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.200702-335OC","article-title":"A new murine model for bronchiolitis obliterans post-bone marrow transplant","volume":"176","author":"A Panoskaltsis-Mortari","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"M Di Nicola","year":"2002","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/icb.2012.60","article-title":"Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?","volume":"91","author":"SP Burr","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"MM Tiemessen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells","volume":"181","author":"F Casiraghi","year":"2008","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","article-title":"Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance","volume":"9","author":"W Ge","year":"2009","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","article-title":"Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells","volume":"52","author":"AM Madec","year":"2009","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"306","author":"DF McAuley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"K Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"K Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/stem.1638","article-title":"Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses","volume":"32","author":"F Yin","year":"2014","journal-title":"Stem Cells"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Moermans C, Lechanteur C, Baudoux E, Giet O, Henket M, <etal>et al<\/etal>. (2014) Impact of Cotransplantation of Mesenchymal Stem Cells on Lung Function After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Following Non-Myeloablative Conditioning. Transplantation.","DOI":"10.1097\/TP.0000000000000068"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/resp.12050","article-title":"Mesenchymal stem cells and the lung","volume":"18","author":"K Sinclair","year":"2013","journal-title":"Respirology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1513\/pats.200804-037DW","article-title":"Stem cells and cell therapies in lung biology and lung diseases","volume":"5","author":"DJ Weiss","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1513\/AnnalsATS.201304-089AW","article-title":"Stem cells and cell therapies in lung biology and diseases: conference report","volume":"10","author":"DJ Weiss","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcb.24783","article-title":"Mesenchymal stem cell trials for pulmonary diseases","volume":"115","author":"MA Antunes","year":"2014","journal-title":"J Cell Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2003-09-3070","article-title":"Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential","volume":"103","author":"A Peister","year":"2004","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"J Tolar","year":"2007","journal-title":"Stem Cells"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1182\/blood-2009-02-204990","article-title":"The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice","volume":"115","author":"RP Hebbel","year":"2010","journal-title":"Blood"},{"key":"ref24","first-page":"115","article-title":"Isolation and Phenotypic Characterization of Lung Fibroblasts","volume":"117","author":"CJ Baglole","year":"2005","journal-title":"Methods in Molecular Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1182\/blood-2009-05-221135","article-title":"IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation","volume":"114","author":"C Bucher","year":"2009","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fonc.2011.00016","article-title":"Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease","volume":"1","author":"P Kebriaei","year":"2011","journal-title":"Front Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/CJI.0b013e3181ab1807","article-title":"HSCT recipients have specific tolerance to MSC but not to the MSC donor","volume":"32","author":"M Sundin","year":"2009","journal-title":"J Immunother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2012.00345","article-title":"Application of MultiStem((R)) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease","volume":"3","author":"B Vaes","year":"2012","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e87238","DOI":"10.1371\/journal.pone.0087238","article-title":"Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo","volume":"9","author":"IA Isakova","year":"2014","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12015-014-9495-2","article-title":"Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation","volume":"10","author":"KN Sivanathan","year":"2014","journal-title":"Stem Cell Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"N Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, <etal>et al<\/etal>. (2014) A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology.","DOI":"10.1016\/j.jcyt.2014.01.029"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1378\/chest.12-2094","article-title":"A placebo-controlled, randomized trial of mesenchymal stem cells in COPD","volume":"143","author":"DJ Weiss","year":"2013","journal-title":"Chest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"A Tzouvelekis","year":"2013","journal-title":"J Transl Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1074-7613(00)80014-X","article-title":"Other functions, other genes: alternative activation of antigen-presenting cells","volume":"10","author":"S Goerdt","year":"1999","journal-title":"Immunity"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00018-009-0026-2","article-title":"The development and function of regulatory T cells","volume":"66","author":"CJ Workman","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jtcvs.2013.09.041","article-title":"Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model","volume":"147","author":"Y Zhao","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","article-title":"Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages","volume":"37","author":"J Kim","year":"2009","journal-title":"Exp Hematol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","article-title":"Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile","volume":"5","author":"J Maggini","year":"2010","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"L936","DOI":"10.1152\/ajplung.90625.2008","article-title":"Lung environment determines unique phenotype of alveolar macrophages","volume":"296","author":"AM Guth","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.intimp.2013.03.002","article-title":"Mesenchymal stem cells reprogram host macrophages to attenuate obliterative bronchiolitis in murine orthotopic tracheal transplantation","volume":"15","author":"Z Guo","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.healun.2010.09.012","article-title":"Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation","volume":"30","author":"DA Grove","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"ref43","first-page":"163","article-title":"New Cell-Based Therapy Paradigm: Induction of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells into Pro-Inflammatory MSC1 and Anti-inflammatory MSC2 Phenotypes","volume":"130","author":"AM Betancourt","year":"2013","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"MN Islam","year":"2012","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1097\/00007890-200005150-00020","article-title":"Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group","volume":"69","author":"J Behr","year":"2000","journal-title":"Transplantation"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trre.2009.01.003","article-title":"Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome?","volume":"23","author":"J Madill","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"L1045","DOI":"10.1152\/ajplung.00353.2013","article-title":"Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression","volume":"306","author":"VP Stober","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/00007890-200110270-00004","article-title":"Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation","volume":"72","author":"TR Ziegler","year":"2001","journal-title":"Transplantation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"AJ Nauta","year":"2006","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"L120","DOI":"10.1152\/ajplung.00240.2013","article-title":"Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs","volume":"306","author":"AM Foskett","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/scrt68","article-title":"Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6","volume":"2","author":"S Danchuk","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2013.328","article-title":"TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds","volume":"134","author":"Y Qi","year":"2014","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"L924","DOI":"10.1152\/ajplung.00439.2001","article-title":"Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair","volume":"282","author":"LB Ware","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"L988","DOI":"10.1152\/ajplung.2000.278.5.L988","article-title":"KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT","volume":"278","author":"A Panoskaltsis-Mortari","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e69299","DOI":"10.1371\/journal.pone.0069299","article-title":"Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study","volume":"8","author":"Y Moodley","year":"2013","journal-title":"PLoS One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1073\/pnas.0704421104","article-title":"Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury","volume":"104","author":"LA Ortiz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/leu.2010.310","article-title":"Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase","volume":"25","author":"R Meisel","year":"2011","journal-title":"Leukemia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:55:03Z","timestamp":1588960503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109034"}},"subtitle":[],"editor":[{"given":"Peter","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109034","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}